Current management of lupus nephritis

Houssiau, Frédéric;Lauwerys, Bernard
(2013) Best Practice & Research: Clinical Rheumatology — Vol. 27, n° 3, p. 319-328 (2013)

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 475.17 KB
Request a copy

Details

Authors
  • Houssiau, FrédéricUCLouvain
    Author
  • Lauwerys, BernardUCLouvain
    Author
Abstract
Despite decades of clinical research aimed at finding the most appropriate immunosuppressive regime, lupus nephritis (LN) remains one of the major disease manifestations of systemic lupus erythematosus (SLE) with a great impact on survival and quality of life. We start this review by defining the disease burden, the real-world challenges and the poor prognostic factors. We then discuss the current anti-inflammatory, cytotoxic and biologic therapies, with special emphasis on the need for optimal global care.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Houssiau, F., & Lauwerys, B. (2013). Current management of lupus nephritis. Best Practice & Research: Clinical Rheumatology, 27(3), 319-328. https://doi.org/10.1016/j.berh.2013.07.004 (Original work published 2013)